Serologic and Histologic Findings in Patients with Capsular Contracture After Breast Augmentation with Smooth Silicone Gel Implants: Is Serum Hyaluronan a Potential Predictor?
- 435 Downloads
In this study, breast implant capsular tissues and blood samples from 25 cases were studied to characterize the relationship between capsular findings and serum analysis. The serum fibrosis indexes hyaluronan and the aminoterminal propeptide of procollagen type III (PIIINP) are fairly well correlated in several other studies with the inflammation grade and fibrosis in patients with progressive fibrotic disorders such as liver cirrhosis.
The study enrolled 25 female patients (average age, 40 ± 12 years) with capsular contracture after bilateral cosmetic breast augmentation using smooth silicone gel implants (Mentor). The implants were placed in a submuscular position through an incision in the inframammary fold. The implant removals were prompted by development of capsular fibrosis (Baker grades 1–4). Samples of capsular tissue were obtained from all the patients for standard histologic and immunohistochemical analyses. Blood samples were drawn from all the patients immediately before surgery. Sera from 20 healthy female patients (average age, 34 ± 9 years) who had undergone plastic surgery for reduction mammaplasty were used as controls.
Histology. Capsular tissue was significantly thicker in patients with grades 3 and 4 contracture than in women with grade 2 contracture according the classification by Baker. There was a moderate (n = 15) or severe (n = 10) chronic inflammatory reaction in the capsules around the implants. Fibroblasts and macrophages represented the major cell population found in the fibrous capsules. In addition, activated CD4+ cells were detected. An inner layer with synovia-like metaplasia and multinucleated giant cells was found. Fibroblast-like cells formed the most common cell type in the capsules, along with macrophages, scattered polymorphonuclear leukocytes, lymphocytes, plasma cells, and mast cells. Serum analysis. There was a significantly higher level (p < 0.05) of hyaluronan serum concentration in patients with capsular contracture (26 ± 14 μg/l) than in control subjects (12 ± 6 μg/l). There was a positive correlation between the grade of capsular contracture (Baker 1–4) and the hyaluronan serum concentration (Baker 1–2: 15 ± 3 μg/l; Baker 3–4: 35 ± 12 μg/l) (r2 =0.73; p < 0.05).
: In this study, serum hyaluronan levels were significantly elevated in patients with constrictive fibrosis after breast augmentation, and there was a positive correlation with the stage of capsular contracture. Serum hyaluronan concentration may help in defining patients at risk for capsular fibrosis. If treatment with new drugs can be started as a preventive measure, it may be possible to reduce the rate of patients who require surgical intervention.
KeywordsCapsular contracture Composition of fibrous capsule Local T-cell immune response Serum fibrosis indexes Serum hyaluronan
- 3.Baran CN, Peker F, Ortak T, Sensoz O, Baran NK: A different strategy in the surgical treatment of capsular contracture: Leave capsule intact. Aesth Plast Surg 25:427–431, 2001Google Scholar
- 8.Burckhardt BR: Capsular contracture: Hard breasts, soft data. Clin Plast Surg 15:521, 1988Google Scholar
- 11.Cimons M: FDA plans safety reviews of several medical devices. Los Angeles Times, April 28, 1992, A-14Google Scholar
- 12.Cunningham B: Update on situation of breast implants in the U.S. Presented at EQUAM’s 3rd Consensus Conference, Regensburg, Germany, 1998Google Scholar
- 13.Deapen DM, Bestein L, Brody GS: Are breast implants anticarcinogenic? A 14-year–follow-up of the Los Angeles Study. Plast Reconst Surg 5:1346–1353, 1997Google Scholar
- 15.Embrey M, Adams EE, Cunningham B, Peters W, Young VL, Carlo GL: A review of the literature on the aetiology of capsular contracture and a pilot study to determine the outcome of capsular contracture interventions. Aesth Plast Surg 23:197–206, 1999Google Scholar
- 16.European Commission: Guidelines for conformity assessment of breast implants according to directive, 93/42/EEC relating to medical devices. European Commission. Directorate—General III Industry, Brussels, July 1998Google Scholar
- 20.Grigg M, Bondurand S, Ernster VL, Herdman R: Information for women about the safety of silicone breast implants. Report of the Institute of Medicine, Washington DC, June 1999Google Scholar
- 21.Gylbert L, Asplund O, Jurell G: Capsular contracture after breast reconstruction with silicone- and saline-filled implants: A 6-year follow-up. Plast Reconstr Surg 86:809–811, 1990Google Scholar
- 22.Heppleston AG, Styles JA, cited by Carr I: The macrophage. Academic Press: London, 1973,84Google Scholar
- 24.Knudson W: The role of CD44 as a cell surface hyaluronan receptor during tumor invasion and metastasis. Frontiers Biosci 3:604–615, 1998Google Scholar
- 27.Markovitz M, Cifonelli JA, Dorfman A: The biosynthesis of hyaluronic acid by group A streptococcus: VI. Biosynthesis from uridine nucleotides in cell-free extracts. J Biol Chem 234:2342–2350, 1959Google Scholar
- 28.Martin-Moreno J, Gorgojo L, Gonzales J, Wiesbaum W: Draft final report study: Health Risk Posed by Silicone Implants in General With a Special Attention to Breast Implants. European Commission Directorate General III Industry, Brussels, March 2000Google Scholar
- 29.Maxwell GP, Lugston PA: Management of complications following augmentation mammaplasty. In: Georgeade GS, Riefkohl R, Levin LS (eds) Georgeade plastic, maxillofacial and reconstructive surgery. 3rd ed. Williams & Wilkins: Baltimore, MD, 1997Google Scholar
- 30.Meyer K, Palmer JW: The polysaccharide of the vitreous humor. J Biol Chem 107:629–634, 1934Google Scholar
- 32.Olivari N: Infection and capsular fibrosis. ISAPS 2004 postgraduate course, Berlin, March 2004Google Scholar
- 34.Peters WJ, Smith D, Lugowsky S: Failure properties of 352 explanted silicone implants: A report of 300 patients. Ann Plast Surg 34:3–6, 1995Google Scholar
- 50.Vasquez B, Given KS, Housten GC: Breast augmentation: Review of subglandular and submascular implantation. Aesth Plast Surg 11:101–105, 1987Google Scholar
- 53.Wick G, Wagner R, Klima G, Wilfingseder P: Immunohistochemical analysis of the connective tissue capsule formation and constriction around mammary silicone prostheses. In: Kano K, Mori S, Sugisaki T, Torisu M (ed) Cellular, molecular, and genetic approaches to immunodiagnosis and immunotherapy. University of Tokyo Press. pp. 231–241, 1987Google Scholar
- 55.Wyatt Lance E, Sinow J, Wollman JS, Sami DABS, Miller TA: The influence of time on human breast capsule histology: Smooth and textured silicone-surfaced implants. Plast Reconstr Surg 102:1922–1931, 1998Google Scholar